Optimizing Analytical Methods to Guarantee Safe, High Quality,
Consistent & Efficacious Gene Therapy Products
In the context of rapid gene therapy progress and mounting regulatory scrutiny, the 2nd Annual
Gene Therapy Analytical Development Summit will virtually unite large pharma and innovative biotechs to discuss the full and comprehensive range of analytical tools required to guarantee the consistency, quality and safety of gene therapy products.
Focused specifically on addressing the unique analytical challenges posed by gene therapy vectors, this technical scientific conference will unite the Analytical Development, QC, CMC, and Process Development leaders grappling with these challenges first-hand.
Incorporating tracks taking a deep dive into bioassays, molecular biology, and analytical chemistry, this is your opportunity to gain extensive technical information enabling you to solve the exact challenges you’re encountering. Enhance your existing analytical methods and explore innovative novel tools to support safe and effective gene therapy development.
Download the full event guide for more information.
World-Class Speaking Faculty
Head of Bioanalytics
Senior Director, Analytical Development Department, CMC Regulatory, Quality & Analytical Development
Executive Director, Analytical Development, Gene Therapy
Head of Quality Control & Analytical Sciences
Quality Assessor & European Medicines Agency (EMA) Expert for ATMPs
Italian Medicines Agency (AIFA)
Head of Gene Therapy CMC Analytics
Director, Analytical Development
Executive Director, Analytical Sciences